PEGASTA 6MG INJ

Price 2840 INR/ Thousand

Get a Price/Quote

PEGASTA 6MG INJ Specification

Origin of Medicine
Biological

Salt Composition
Pegfilgrastim 6 mg

Dosage Form
Injection

Indication
Prevention of neutropenia in chemotherapy

Pacakaging (Quantity Per Box)
1 Syringe

Drug Type
Biological

Ingredients
Pegfilgrastim

Physical Form
Injection

Function
Stimulates production of white blood cells

Recommended For
Cancer patients undergoing chemotherapy

Dosage
6 mg

Dosage Guidelines
As directed by the physician

Suitable For
Adults

Quantity
1 prefilled syringe

Storage Instructions
Store at 2C-8C, do not freeze

Use Under Medical Supervision
Yes

Warning
For hospital and prescription use only

Container Type
Prefilled syringe with safety device

Marketed By
Intas Pharmaceuticals Ltd.

Prescription Required
Yes

Route of Administration
Subcutaneous injection

Appearance
Clear, colorless solution

Brand Name
PEGASTA 6MG INJ

Therapeutic Class
Hematopoietic Agents

Shelf Life
24 months from the date of manufacture

About PEGASTA 6MG INJ

Pegasta Injection is used to prevent infections after chemotherapy. It is a growth factor that stimulates bone marrow to produce white blood cells. These cells protect the body against infections.Pegasta Injection is given as an injection by a qualified medical professional. You should continue to take as long as your doctor advises for it. The duration of treatment varies according to your need and response to treatment. You might be asked for regular tests done to check the number of blood cells in your blood and your bone density level while you are taking this medicine.The most common side effects of this medicine include bone pain, joint pain, headache, nausea, and muscle pain. Other than this, pain or redness at the site of injection is common. But, inform your doctor if you notice a lump, swelling, or bruising that does not go away. It might not prevent you from all kinds of infection, hence inform your doctor if you notice fever, chills, shortness of breath, sore throat, and swelling around the face or neck.Many other medicines can affect, or be affected by, this medicine so let your healthcare team know all medications you are using. This medicine is not recommended during pregnancy or while breastfeeding. The use of effective contraception by both males and females during treatment is important to avoid pregnancy. You must avoid driving or attention-seeking activity if you experience dizziness after taking this medicine

Mechanism of Action

PEGASTA 6MG INJ contains Pegfilgrastim, a long-acting hematopoietic agent. By mimicking the body's natural growth factor, it stimulates the bone marrow to produce more white blood cells, specifically neutrophils. This increases immunity and reduces infection risk during chemotherapy treatments.

Administration and Dosage

PEGASTA 6MG INJ is administered subcutaneously by healthcare professionals. The recommended dosage is 6 mg, delivered via a prefilled syringe equipped with a safety device. Dosage schedules are determined by the treating physician based on individual patient needs and chemotherapy protocols.

Storage and Handling

Proper storage is crucial for maintaining PEGASTA 6MG INJ's efficacy. It should be kept refrigerated at 2C-8C, and must not be frozen. The prefilled syringe ensures convenient and safe administration, and every dose must be handled according to hospital protocols to guarantee patient safety.

FAQ's of PEGASTA 6MG INJ:

Q: How is PEGASTA 6MG INJ administered to patients?

A: PEGASTA 6MG INJ is given as a subcutaneous injection by healthcare professionals in a hospital or clinic setting. The medicine comes in a prefilled syringe with a safety device, ensuring precise and safe dosing.

Q: What is the main benefit of using PEGASTA 6MG INJ during chemotherapy?

A: The primary benefit of PEGASTA 6MG INJ is its ability to boost white blood cell production, reducing the risk of neutropenia and infection in cancer patients undergoing chemotherapy. This helps improve overall patient outcomes and supports uninterrupted treatment.

Q: When should PEGASTA 6MG INJ be taken during chemotherapy?

A: PEGASTA 6MG INJ is typically administered once per chemotherapy cycle, as directed by a physician. The exact timing depends on individual patient needs and the specific chemotherapy regimen in use.

Q: Where should PEGASTA 6MG INJ be stored before use?

A: PEGASTA 6MG INJ should be stored in a refrigerator at temperatures between 2C and 8C, away from direct sunlight. It must not be frozen, as freezing can damage the medicine and reduce its effectiveness.

Q: What process should be followed for using PEGASTA 6MG INJ safely?

A: Use of PEGASTA 6MG INJ must adhere to strict hospital protocols. Only qualified healthcare professionals should administer the injection, following dosage and handling instructions as directed by the prescribing physician.

Q: Is PEGASTA 6MG INJ suitable for all cancer patients?

A: PEGASTA 6MG INJ is intended for adults receiving chemotherapy who are at risk of neutropenia. Suitability is determined by a physician based on medical evaluation, and it is not recommended for use without a prescription.

Q: Do I need a prescription to purchase PEGASTA 6MG INJ?

A: Yes, PEGASTA 6MG INJ is a prescription-only medicine for hospital use, and must be prescribed by a qualified physician. Its administration and handling require medical supervision.

Tell us about your requirement